KDIGO, 2021

The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease (CKD) represents an update to the 2012 KDIGO guideline. The scope includes topics such as optimal blood pressure targets, lifestyle interventions, and antihypertensive therapies in CKD patients not receiving dialysis, including special populations such as kidney transplant recipients and children.

The goal of the guideline is to serve as a useful resource for clinicians and patients by providing actionable recommendations with useful infographics based on a formal systematic review.

The guideline provides a chapter dedicated to proper blood pressure measurement, plus states recommendations for treatment of high blood pressure in CKD according to albumin-creatinine ratio (ACR) levels, which can be obtained via ACR point-of-care testing. Specifically, it provides recommendations for treatment initiation in this patient group, with renin-angiotensin-system inhibitors (RASI), where moderate to severe albuminuria is present.

The full publication can be accessed here.

COL-08887 10/2021